While we did not test DABIL‐4 tumors against IL‐4R‐negative tumors, these results strongly suggest that the depletion of PMN‐MDSCs and M2‐like macrophages in 4T1 tumor‐bearing mice accounts for a significant degree of DABIL‐4 antitumor efficacy. Here, IL4R is linked to neoplasm.